JP2022550608A5 - - Google Patents

Info

Publication number
JP2022550608A5
JP2022550608A5 JP2022520780A JP2022520780A JP2022550608A5 JP 2022550608 A5 JP2022550608 A5 JP 2022550608A5 JP 2022520780 A JP2022520780 A JP 2022520780A JP 2022520780 A JP2022520780 A JP 2022520780A JP 2022550608 A5 JP2022550608 A5 JP 2022550608A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
cells
fusion protein
disease
prion disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022520780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550608A (ja
JP7824873B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054140 external-priority patent/WO2021067864A1/en
Publication of JP2022550608A publication Critical patent/JP2022550608A/ja
Publication of JP2022550608A5 publication Critical patent/JP2022550608A5/ja
Application granted granted Critical
Publication of JP7824873B2 publication Critical patent/JP7824873B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022520780A 2019-10-02 2020-10-02 プリオン病の治療のためのジンクフィンガータンパク質転写因子 Active JP7824873B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962909725P 2019-10-02 2019-10-02
US62/909,725 2019-10-02
US202063023197P 2020-05-11 2020-05-11
US63/023,197 2020-05-11
PCT/US2020/054140 WO2021067864A1 (en) 2019-10-02 2020-10-02 Zinc finger protein transcription factors for treatment of prion disease

Publications (3)

Publication Number Publication Date
JP2022550608A JP2022550608A (ja) 2022-12-02
JP2022550608A5 true JP2022550608A5 (cg-RX-API-DMAC7.html) 2023-09-29
JP7824873B2 JP7824873B2 (ja) 2026-03-05

Family

ID=73013822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520780A Active JP7824873B2 (ja) 2019-10-02 2020-10-02 プリオン病の治療のためのジンクフィンガータンパク質転写因子

Country Status (5)

Country Link
US (1) US20230002459A1 (cg-RX-API-DMAC7.html)
EP (1) EP4041271A1 (cg-RX-API-DMAC7.html)
JP (1) JP7824873B2 (cg-RX-API-DMAC7.html)
CN (1) CN114728037A (cg-RX-API-DMAC7.html)
WO (1) WO2021067864A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026506083A (ja) 2023-02-17 2026-02-20 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ エピジェネティック修飾を行うための組成物および方法
WO2025160155A1 (en) 2024-01-22 2025-07-31 The Broad Institute, Inc. Epigenetic targeting of prion diseases
WO2025194009A1 (en) * 2024-03-13 2025-09-18 Sangamo Therapeutics, Inc. Zinc finger proteins for treating prion disease
WO2026133078A1 (en) 2024-12-17 2026-06-25 Fondazione Telethon Ets Therapeutic strategy for treating copper-mediated pathologies

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420032A (en) 1991-12-23 1995-05-30 Universitge Laval Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
US5792632A (en) 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
JP4012243B2 (ja) 1994-01-18 2007-11-21 ザ スクリップス リサーチ インスティチュート 亜鉛フィンガータンパク質誘導体およびそのための方法
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
CA2196419C (en) 1994-08-20 2007-08-21 Yen Choo Improvements in or relating to binding proteins for recognition of dna
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
BR0109521A (pt) * 2000-03-24 2003-06-10 Univ Massachusetts Public Inst Ungulados transgênicos sem prìons
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US20050235369A1 (en) * 2001-03-28 2005-10-20 Yen Choo Gene regulation II
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
AU2002326483A1 (en) * 2001-07-31 2003-02-17 Simon Eric Aspland Genetically modified cows having reduced susceptibility to mad cow disease
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
DK3246403T3 (da) 2005-10-18 2020-10-26 Prec Biosciences Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet
US20110023147A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of prion disorder-related genes in animals
EP2566972B1 (en) 2010-05-03 2020-01-15 Sangamo Therapeutics, Inc. Compositions for linking zinc finger modules
AU2011256838B2 (en) 2010-05-17 2014-10-09 Sangamo Therapeutics, Inc. Novel DNA-binding proteins and uses thereof
US20120225922A1 (en) * 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
CN102277356B (zh) * 2011-07-28 2012-10-03 扬州大学 一种山羊朊病毒基因敲除方法
IL264792B2 (en) 2016-08-24 2023-10-01 Sangamo Therapeutics Inc Engineered target-specific zinc-finger nucleases

Similar Documents

Publication Publication Date Title
Feng et al. Neutrophil extracellular traps exacerbate secondary injury via promoting neuroinflammation and blood–spinal cord barrier disruption in spinal cord injury
Kamei et al. Effect of an enhanced nose-to-brain delivery of insulin on mild and progressive memory loss in the senescence-accelerated mouse
Birch The contribution of astrocytes to Alzheimer's disease
Stowe et al. CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke
Corrigan et al. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains
Chatziralli et al. Intravitreal anti-vascular endothelial growth factor agents for the treatment of diabetic retinopathy: a review of the literature
AU2018225493B2 (en) Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases
US20150353641A1 (en) Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
Weber-Adrian et al. Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease
JP7812364B2 (ja) 好中球性皮膚症の処置のための抗il-36r抗体
Yin et al. Optic nerve regeneration: A long view
Majdi et al. The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine
JP2023511908A5 (cg-RX-API-DMAC7.html)
Guo et al. Fasudil reduces β-amyloid levels and neuronal apoptosis in APP/PS1 transgenic mice via inhibition of the Nogo-A/NgR/RhoA signaling axis
Li et al. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Wu et al. Administration of rTMS alleviates stroke-induced cognitive deficits by modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis
JP2022551286A5 (cg-RX-API-DMAC7.html)
US20240238363A1 (en) Oral peptide antagonists of multiple chemokine receptors for reversing loss of synapses and dendritic spines
CN114533720A (zh) Cd36抑制剂在制备抑制脊髓损伤后疤痕形成药物中的应用
Sussman et al. Neural tropomodulin: developmental expression and effect of seizure activity
Ghanem et al. Impact of berberine on some epigenetic, transcription regulation and inflammatory biomarkers in a mice model of epilepsy
Lefebvre-Roque et al. Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice
Péladeau et al. Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy
F. Abisambra et al. Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics
CN115475247A (zh) β2-微球蛋白或其抑制剂的制药用途